FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in Geneva, Switzerland

Biotech startups in Geneva, Switzerland

Updated 16 Nov 2026

Reset
Biotech startups in Geneva, Switzerland
One-time CSV
  • 21 funded companies, 8 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~geneva-geneve.csv21 rows × 18 columns
CompanyCityLast roundAmountDate
FluoSpheraGenevaSeed$1.4M2026-01-12
iOncturaGenevaSeries B$85.7M2024-06-20
NeurosterixGenevaSeries A$65.0M2024-04-03
AdipossGenevaSeries A$5.0M2025-06-30
ViroblockGenevaSeries C$4.5M2012-02-14
PregLemGenevaSeries B$32.2M2007-12-04

6 rows of the CSV in 5 of its 18 columns.

21
Startups
$182.5M
Total raised
3
Funded in the last 12 months
$22.0M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

14 of 21
14 rows
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
FluoSphera FluoSphera develops drugs. Biotech Seed $1.4M 2026-01-12 $3.9M SOSV, SOSV SF & NY (Fka IndieBio), FONGIT Innovation Fund +2 1 to 10 2021
Adiposs Adiposs SA is a clinical-stage life science company developing a first-in-class imaging product for cancer patients. Biotech Series A $5.0M 2025-06-30 $7.4M MassChallenge, Venture Kick, FONGIT Innovation Fund +2 1 to 10 2020
iOnctura iOnctura is a clinical-stage biotechnology company developing treatments for cancer. Biotech Series B $85.7M 2024-06-20 European Innovation Council, M Ventures, VI Partners +2 11 to 50 2017
Neurosterix Neurosterix is a biopharmaceutical firm creating allosteric modulators for neurological illnesses. Biotech Series A $65.0M 2024-04-03 $65.0M Perceptive Advisors, Xontogeny, Acorn Bioventures 11 to 50 2024
Kejako Kejako develops a non-invasive solution helping presbyopic patients keep their quality of life. Biotech Seed $789K 2022-08-01 MassChallenge, Business Angels Switzerland (BAS), FONGIT 1 to 10 2015
Chord Therapeutics Chord Therapeutics is a clinical stage biopharmaceutical company developing drugs for rare diseases. Biotech Series A $16.0M 2020-10-13 Omega Funds, Eclosion SA 1 to 10 2014
MaxiVAX MaxiVAX is a Swiss clinical-stage biotechnology company. Biotech Series B $5.0M 2019-11-27 EIC Accelerator 1 to 10 2005
Amal Therapeutics Amal Therapeutics SA is a privately held Swiss and German biotech startup spun off from the University of Geneva. Biotech Series B $32.6M 2018-11-12 HTGF (High-Tech Gruenderfonds), Venture Kick, VI Partners +2 11 to 50 2012
Andrew Alliance Andrew Alliance is a Swiss pioneer in robotics for the life sciences sector. Artificial intelligence Series C $14.0M 2018-06-12 Venture Kick, Omega Funds, Rancilio Cube Sicaf 11 to 50 2011
Intelligent Sensory concept Intelligent Sensory concept is a biotechnology company that specializes in photomodulation. Biotech Series A $2.0M 2018-05-18 Rhône Finance 11 to 50 2015
Endosense Endosense develops medical technology that improves the reproducibility of catheter ablation for cardiac arrhythmias. Biotech Series C $41.2M 2013-11-27 3i Group, VI Partners, Andera Partners +2 51 to 100 2003
Mind-NRG Mind-NRG develops peptidic neurotrophic factors for psychiatric and neurologic diseases. Biotech Series B $7.9M 2013-09-04 Index Ventures, Limburgse Reconversie Maatschappij 1 to 10 2010
Viroblock Viroblock is a Swiss company developing antiviral technology for air filtration products. Biotech Series C $4.5M 2012-02-14 $4.5M StartAngels Network, BlueOcean Ventures 1 to 10 2005
PregLem PregLem is a Swiss biopharmaceutical company that develops and commercializes new drugs. Biotech Series B $32.2M 2007-12-04 $58.2M Sofinnova Partners, Sofinnova Investments, MVM Life Science Partners +1 11 to 50 2006

Table 1. Biotech startups in Geneva, Switzerland: the 14 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 21.

Largest rounds

Last 12 months
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 FluoSphera FluoSphera develops drugs. Biotech Seed $1.4M 2026-01-12 $3.9M SOSV, SOSV SF & NY (Fka IndieBio), FONGIT Innovation Fund +2 1 to 10 2021

Table 2. Biotech startups in Geneva, Switzerland: the 1 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Eclosion SA Venture capital firm Geneva, Switzerland 4 19%
2 FONGIT Innovation Fund Startup incubator Geneva, Switzerland 3 14% 1 FluoSphera
3 VI Partners Venture capital firm Altendorf, Switzerland 3 14%
4 Venture Kick Startup incubator Schlieren, Switzerland 3 14%
5 Omega Funds Secondary purchaser Boston, United States 2 10%
6 MassChallenge Startup accelerator Boston, United States 2 10%
7 SOSV SF & NY (Fka IndieBio) Venture capital firm San Francisco, United States 1 5% 1 FluoSphera
8 SOSV Venture capital firm Princeton, United States 1 5% 1 FluoSphera
9 Mountain Labs Startup incubator Saanen, Switzerland 1 5% 1 FluoSphera
10 EFI Lake Geneva Ventures Venture capital firm Geneva, Switzerland 1 5% 1 FluoSphera
11 Schroders Capital Private equity firm London, United Kingdom 1 5%
12 M Ventures Corporate venture arm Amsterdam, The Netherlands 1 5%
13 European Innovation Council Startup accelerator Brussels, Belgium 1 5%
14 Xontogeny Startup accelerator Boston, United States 1 5%
15 Perceptive Advisors Hedge fund New York, United States 1 5%

Table 3. Biotech startups in Geneva, Switzerland: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 17 81% $131.8M
Artificial intelligence 1 5%
Hardware 1 5%
Software 1 5%
Fintech 1 5%

Table 4. Biotech startups in Geneva, Switzerland by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 1 5% $124K
Seed 6 29% $1.0M
Series A 5 24% $16.0M
Series B 5 24% $32.2M
Series C 4 19% $14.0M

Table 5. Biotech startups in Geneva, Switzerland by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
June 2026 1 33% $124K
April 2026 1 33% $20.5M
January 2026 1 33% $1.4M

Table 6. Biotech startups in Geneva, Switzerland: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 3 14% $22.0M
2025 1 5% $5.0M
2024 2 10% $150.7M
2022 1 5% $789K
2021 1 5% $1.0M
2020 1 5% $16.0M

Table 7. Biotech startups in Geneva, Switzerland by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 2 10%
2020 to 2022 3 14%
2015 to 2019 4 19%
2010 to 2014 8 38%
Before 2010 4 19%

Table 8. Biotech startups in Geneva, Switzerland by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 12 57%
11 to 50 8 38%
51 to 100 1 5%

Table 9. Biotech startups in Geneva, Switzerland by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Geneva, Switzerland are on the list?
21, in the file dated 16 November 2026. 3 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 21 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in Geneva, Switzerland: 21 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Other sectors in Geneva

Biotech startups elsewhere

Cite: FundingWatcher, 21 funded biotech companies in Geneva, Switzerland, 16 November 2026. https://fundingwatcher.com/startups/biotech/geneva-geneve/